Active Biotech Valuation
| ACTI Stock | SEK 0.27 0.02 8.00% |
Active Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Active Biotech AB from analyzing the firm fundamentals such as Return On Equity of -1.44, current valuation of 224.92 M, and Shares Owned By Insiders of 45.94 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Active Biotech's price fluctuation is out of control at this time. Calculation of the real value of Active Biotech AB is based on 3 months time horizon. Increasing Active Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Active Biotech's intrinsic value may or may not be the same as its current market price of 0.27, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.27 | Real 0.24 | Hype 0.27 | Naive 0.25 |
The intrinsic value of Active Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Active Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Active Biotech AB helps investors to forecast how Active stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Active Biotech more accurately as focusing exclusively on Active Biotech's fundamentals will not take into account other important factors: Active Biotech Total Value Analysis
Active Biotech AB is presently anticipated to have takeover price of 224.92 M with market capitalization of 268.37 M, debt of 200 K, and cash on hands of 53.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Active Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
224.92 M | 268.37 M | 200 K | 53.13 M |
Active Biotech Asset Utilization
One of the ways to look at asset utilization of Active is to check how much profit was generated for every dollar of assets it reports. Active Biotech AB shows a negative utilization of assets of -0.67 percent, losing kr0.006714 for each kronor of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each kronor of assets it shows. Put another way, asset utilization of Active Biotech AB shows how discouraging it operates for each kronor spent on its assets.Active Biotech Ownership Allocation
Active Biotech holds a total of 264.89 Million outstanding shares. Active Biotech AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Active Biotech Profitability Analysis
Net Loss for the year was (49.83 M) with profit before overhead, payroll, taxes, and interest of 6.72 M.About Active Biotech Valuation
The stock valuation mechanism determines Active Biotech's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Active Biotech AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Active Biotech. We calculate exposure to Active Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Active Biotech's related companies.Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
8 Steps to conduct Active Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Active Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Active Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Active Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Active Biotech's revenue streams: Identify Active Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Active Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Active Biotech's growth potential: Evaluate Active Biotech's management, business model, and growth potential.
- Determine Active Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Active Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.